Tobacco smoking influences the side effects of radiation therapy-managed patients with various malignancies: A systematic review
Journal of Medical Imaging and Radiation Sciences, ISSN: 1939-8654, Vol: 55, Issue: 4, Page: 101430
2024
- 8Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures8
- Readers8
Review Description
Tobacco smoking may decrease the effectiveness of radiation therapy. This is because tobacco smoking can cause inflammation and damage to surrounding tissues, which may interfere with radiation delivery to the tumor. Our aim of this study is to investigate the effect of tobacco smoking use on complications in radiotherapy as a systematic review. The articles searched from the MEDLINE, PubMed, EMBASE, and Web of Science databases. The search terms used were “radiotherapy”, “outcome”, “radiation therapy”, “tobacco”, “smoking”, “complications”, “side effects”, “cancer”, and “malignancy”. PRISMA check list was used to assess the overall quality of evidence for each outcome. The outcomes of radiotherapy-inducing tobacco smoking in smokers are more than non-smokers including; high SPC (second primary cancer), decreased median overall survival, higher infections during treatment, increased fatigue ( p = 0.027), increased pain ( p = 0.009), poorer cognitive function (0.041), affected mouth opening (0.049), more speech disturbances ( p = 0.017), higher metastasis risk ( p = 0.031 and 0.019), higher locoregional recurrence risk ( p = 0.027), oral mucositis ( p = 0.03), mucositis severity related to higher tobacco exposure ( p = 0.008), severe acute radiation skin reactions, and myocardial infarction. Tobacco smoking appears to be the most significant modifiable factor influencing cancer treatment outcomes. As such, healthcare providers should take detailed notes on patients' smoking histories during both routine and future clinical studies. Beyond immediate cessation, cancer patients should undertake comprehensive smoking cessation programs. These programs can significantly boost the efficacy of radiotherapy and enhance overall patient outcomes. Le tabagisme peut diminuer l'efficacité de la radiothérapie. En effet, le tabagisme peut provoquer une inflammation et endommager les tissus environnants, ce qui peut interférer avec l'irradiation de la tumeur. L'objectif de cette étude est d'examiner l'effet du tabagisme sur les complications de la radiothérapie dans le cadre d'une analyse systématique. Les articles ont été recherchés dans les bases de données MEDLINE, PubMed, EMBASE et Web of Science. Les termes de recherche utilisés étaient « radiotherapy », « outcome », « radiation therapy », « tobacco », « smoking », « complications », « side effects », « cancer » et « malignancy ». La liste de contrôle PRISMA a été utilisée pour évaluer la qualité globale des preuves pour chaque résultat. Les conséquences du tabagisme induit par la radiothérapie chez les fumeurs sont plus importantes que chez les non-fumeurs, notamment: un taux élevé de DCP (deuxième cancer primaire), une diminution de la survie globale médiane, un nombre plus élevé d'infections pendant le traitement, une fatigue accrue ( p = 0,027), une douleur accrue ( p = 0,009), des fonctions cognitives moins bonnes (0, 041), ouverture de la bouche affectée (0,049), plus de troubles de la parole ( p = 0,017), risque de métastases plus élevé ( p = 0,031 et 0,019), risque de récidive locorégionale plus élevé ( p = 0,027), mucosite orale ( p = 0,03), gravité de la mucosite liée à une plus grande exposition au tabac ( p = 0,008), réactions cutanées aiguës graves aux radiations et infarctus du myocarde. Le tabagisme semble être le facteur modifiable le plus important influençant les résultats du traitement du cancer. C'est pourquoi les fournisseurs de soins de santé devraient prendre des notes détaillées sur les antécédents tabagiques des patients au cours des études cliniques de routine et futures. Au-delà de l'arrêt immédiat, les patients atteints de cancer devraient entreprendre des programmes complets de sevrage tabagique. Ces programmes peuvent considérablement renforcer l'efficacité de la radiothérapie et améliorer les résultats globaux des patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1939865424001498; http://dx.doi.org/10.1016/j.jmir.2024.05.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85195690405&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/38870612; https://linkinghub.elsevier.com/retrieve/pii/S1939865424001498; https://dx.doi.org/10.1016/j.jmir.2024.05.003
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know